GSK Pauses RSV Vaccine Study In Pregnant Women Over Safety Concern

Delay Could Hand Advantage To Pfizer

 
• By Andrew McConaghie
  
Pregnant woman vaccination
GSK and Pfizer are both developing matneral RSV vaccines which aim to pass on immunity against the virus to their unborn infants. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D